Host glycans and antigen presentation

Microbes and Infection

Volumn 14, Issue 11, 2012, Pages 894-903

  Ryan, Sean O ^a   Cobb, Brian A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presentation; Glycosylation; HLA; MHC class I; MHC class II; N glycan

Indexed keywords

CD1 ANTIGEN; GALACTOSE; GLUCOSE; GLYCOLIPID; GLYCOPROTEIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE; N ACETYLGLUCOSAMINE; SIALIC ACID; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; BACTERIAL COLONIZATION; CELLULAR IMMUNITY; CYTOLYSIS; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROPHOBICITY; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; SHORT SURVEY; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; GLYCOSYLATION; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYSACCHARIDES;

EID: 84865533313     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.04.010     Document Type: Short Survey

References (72)

1. Braem K., Lories R.J. Insights into the pathophysiology of ankylosing spondylitis: contributions from animal models. Jt. Bone Spine 2011.
2. Tam L.S., Gu J., Yu D. Pathogenesis of ankylosing spondylitis. Nat. Rev. Rheumatol. 2010, 6:399-405.
3. Kumánovics A., Takada T., Lindahl K.F. Genomic organization of the mammalian MHC. Annu. Rev. Immunol. 2003, 21:629-657.
4. Neefjes J., Jongsma M.L., Paul P., Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 2011, 11:823-836.
5. Koller B.H., Marrack P., Kappler J.W., Smithies O. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science 1990, 248:1227-1230.
6. Madsen L., Labrecque N., Engberg J., Dierich A.E., Svejgaard A., Benoist C., Mathis D., Fugger L. Mice lacking all conventional MHC class II genes. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10338-10343.
7. Brigl M., Brenner M.B. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 2004, 22:817-890.
8. Marth J.D., Grewal P.K. Mammalian glycosylation in immunity. Nat. Rev. Immunol. 2008, 8:874-887.
9. Cobb B.A., Wang Q., Tzianabos A.O., Kasper D.L. Polysaccharide processing and presentation by the MHCII pathway. Cell 2004, 117:677-687.
10. Cobb B.A., Kasper D.L. Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR. Glycobiology 2008, 18:707-718.
11. Tzianabos A.O., Wang J.Y., Lee J.C. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc. Natl. Acad. Sci. U. S. A 2001, 98:9365-9370.
12. Kappler J., White J., Kozono H., Clements J., Marrack P. Binding of a soluble alpha beta T-cell receptor to superantigen/major histocompatibility complex ligands. Proc. Natl. Acad. Sci. U. S. A 1994, 91:8462-8466.
13. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 1985, 54:631-664.
14. Parham P. Functions for MHC class I carbohydrates inside and outside the cell. Trends Biochem. Sci. 1996, 21:427-433.
15. Trombetta E.S., Helenius A. Lectins as chaperones in glycoprotein folding. Curr. Opin. Struct. Biol. 1998, 8:587-592.
16. Schachter H. Mgat1-dependent N-glycans are essential for the normal development of both vertebrate and invertebrate metazoans. Semin. Cell Dev. Biol. 2010, 21:609-615.
17. Wang Y., Tan J., Sutton-Smith M., Ditto D., Panico M., Campbell R.M., Varki N.M., Long J.M., Jaeken J., Levinson S.R., Wynshaw-Boris A., Morris H.R., Le D., Dell A., Schachter H., Marth J.D. Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology 2001, 11:1051-1070.
18. Demetriou M., Granovsky M., Quaggin S., Dennis J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001, 409:733-739.
19. Lowe J.B., Marth J.D. A genetic approach to Mammalian glycan function. Annu. Rev. Biochem. 2003, 72:643-691.
20. Bergeron J.J., Zapun A., Ou W.J., Hemming R., Parlati F., Cameron P.H., Thomas D.Y. The role of the lectin calnexin in conformation independent binding to N-linked glycoproteins and quality control. Adv. Exp. Med. Biol. 1998, 435:105-116.
21. Saito Y., Ihara Y., Leach M.R., Cohen-Doyle M.F., Williams D.B. Calreticulin functions in vitro as a molecular chaperone for both glycosylated and non-glycosylated proteins. EMBO J. 1999, 18:6718-6729.
22. Sola R.J., Griebenow K. Effects of glycosylation on the stability of protein pharmaceuticals. J. Pharm. Sci. 2009, 98:1223-1245.
23. Grigorian A., Torossian S., Demetriou M. T-cell growth, cell surface organization, and the galectin-glycoprotein lattice. Immunol. Rev. 2009, 230:232-246.
24. Rudd P.M., Wormald M.R., Stanfield R.L., Huang M., Mattsson N., Speir J.A., DiGennaro J.A., Fetrow J.S., Dwek R.A., Wilson I.A. Roles for glycosylation of cell surface receptors involved in cellular immune recognition. J. Mol. Biol. 1999, 293:351-366.
25. Barbosa J.A., Santos-Aguado J., Mentzer S.J., Strominger J.L., Burakoff S.J., Biro P.A. Site-directed mutagenesis of class I HLA genes. Role of glycosylation in surface expression and functional recognition. J. Exp. Med. 1987, 166:1329-1350.
26. Wearsch P.A., Cresswell P. The quality control of MHC class I peptide loading. Curr. Opin. Cell Biol. 2008, 20:624-631.
27. Cresswell P., Bangia N., Dick T., Diedrich G. The nature of the MHC class I peptide loading complex. Immunol. Rev. 1999, 172:21-28.
28. Rudd P.M., Elliott T., Cresswell P., Wilson I.A., Dwek R.A. Glycosylation and the immune system. Science 2001, 291:2370-2376.
29. Barber L.D., Patel T.P., Percival L., Gumperz J.E., Lanier L.L., Phillips J.H., Bigge J.C., Wormwald M.R., Parekh R.B., Parham P. Unusual uniformity of the N-linked oligosaccharides of HLA-A, -B, and -C glycoproteins. J. Immunol. 1996, 156:3275-3284.
30. An H.J., Froehlich J.W., Lebrilla C.B. Determination of glycosylation sites and site-specific heterogeneity in glycoproteins. Curr. Opin. Chem. Biol. 2009, 13:421-426.
31. Le A.V., Doyle D. Differential regulation of mouse H-2 alloantigens. Biochemistry 1982, 21:5730-5738.
32. Baba E., Erskine R., Boyson J.E., Cohen G.B., Davis D.M., Malik P., Mandelboim O., Reyburn H.T., Strominger J.L. N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors. Hum. Immunol. 2000, 61:1202-1218.
33. Swiedler S.J., Freed J.H., Tarentino A.L., Plummer T.H., Hart G.W. Oligosaccharide microheterogeneity of the murine major histocompatibility antigens. Reproducible site-specific patterns of sialylation and branching in asparagine-linked oligosaccharides. J. Biol. Chem. 1985, 260:4046-4054.
34. Abi-Rached L., Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J. Exp. Med. 2005, 201:1319-1332.
35. Parham P. NK cell receptors: of missing sugar and missing self. Curr. Biol. 2000, 10:R195-R197.
36. Beck S., Trowsdale J. The human major histocompatibility complex: lessons from the DNA sequence. Annu. Rev. Genomics Hum. Genet. 2000, 1:117-137.
37. Gauthier L., Smith K.J., Pyrdol J., Kalandadze A., Strominger J.L., Wiley D.C., Wucherpfennig K.W. Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein. Proc. Natl. Acad. Sci. U. S. A 1998, 95:11828-11833.
38. Salomonsen J., Marston D., Avila D., Bumstead N., Johansson B., Juul-Madsen H., Olesen G.D., Riegert P., Skjodt K., Vainio O., Wiles M.V., Kaufman J. The properties of the single chicken MHC classical class II a chain (B-LA) gene indicate an ancient origin for the DR/E-like isotype of class II molecules. Immunogenetics 2003, 55:605-614.
39. Elliott W.L., Stille C.J., Thomas L.J., Humphreys R.E. An hypothesis on the binding of an amphipathic, alpha helical sequence in Ii to the desetope of class II antigens. J. Immunol. 1987, 138:2949-2952.
40. Ishikawa S., Kowal C., Cole B., Thomson C., Diamond B. Replacement of N-glycosylation sites on the MHC class II E alpha chain. Effect on thymic selection and peripheral T cell activation. J. Immunol. 1995, 154:5023-5029.
41. Neumann J., Koch N. A novel domain on HLA-DRá chain regulates the chaperone role of the invariant chain. J. Cell Sci. 2006, 119:4207-4214.
42. Romagnoli P., Germain R.N. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med. 1994, 180:1107-1113.
43. Bakke O., Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990, 63:707-716.
44. Bakke O., Nordeng T.W. Intracellular traffic to compartments for MHC class II peptide loading: signals for endosomal and polarized sorting. Immunol. Rev. 1999, 172:171-187.
45. Sevilla L.M., Comstock S.S., Swier K., Miller J. Endoplasmic reticulum-associated degradation-induced dissociation of class II invariant chain complexes containing a glycosylation-deficient form of p41. J. Immunol. 2004, 173:2586-2593.
46. Neumann J., Schach N., Koch N. Glycosylation signals that separate the trimerization from the MHC class II-binding domain control intracellular degradation of invariant chain. J. Biol. Chem. 2001, 276:13469-13475.
47. Wei B.Y., Buerstedde J.M., Bell M., Chase C., Nilson A., Browne A., Pease L., McKean D.J. Functional effects of N-linked oligosaccharides located on the external domain of murine class II molecules. J. Immunol. 1991, 146:2358-2366.
48. Frohman M., Cowing C. Presentation of antigen by B cells: functional dependence on radiation dose, interleukins, cellular activation, and differential glycosylation. J. Immunol. 1985, 134:2269-2275.
49. Ryan S.O., Bonomo J.A., Zhao F., Cobb B.A. MHCII glycosylation modulates Bacteroides fragilis carbohydrate antigen presentation. J. Exp. Med. 2011, 208:1041-1053.
50. Brubaker J.O., Li Q., Tzianabos A.O., Kasper D.L., Finberg R.W. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro. J. Immunol. 1999, 162:2235-2242.
51. Stingele F., Corthesy B., Kusy N., Porcelli S.A., Kasper D.L., Tzianabos A.O. Zwitterionic polysaccharides stimulate T cells with no preferential Vbeta usage and promote anergy, resulting in protection against experimental abscess formation. J. Immunol. 2004, 172:1483-1490.
52. Tzianabos A.O., Onderdonk A.B., Rosner B., Cisneros R.L., Kasper D.L. Structural features of polysaccharides that induce intra-abdominal abscesses. Science 1993, 262:416-419.
53. Velez C.D., Lewis C.J., Kasper D.L., Cobb B.A., Type I. Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation. Immunology 2009, 127:73-82.
54. Gibson F.C., Onderdonk A.B., Kasper D.L., Tzianabos A.O. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis. J. Immunol. 1998, 160:5000-5006.
55. Tzianabos A.O., Pantosti A., Baumann H., Brisson J.R., Jennings H.J., Kasper D.L. The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. J. Biol. Chem. 1992, 267:18230-18235.
56. Young N.M., Kreisman L.S., Stupak J., Maclean L.L., Cobb B.A., Richards J.C. Structural characterization and MHCII-dependent immunological properties of the zwitterionic O-chain antigen of Morganella morganii. Glycobiology 2011, 21:1266-1276.
57. Brockhausen I., Schachter H., Stanley P. O-GalNAc glycans. Essentials of Glycobiology 2009, 115-127. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. second ed. A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart, M.E. Etzler (Eds.).
58. Stanley P., Schachter H., Taniguchi N. N-glycans. Essentials of Glycobiology 2009, 101-114. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. second ed. A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart, M.E. Etzler (Eds.).
59. Cooke C.L., An H.J., Kim J., Canfield D.R., Torres J., Lebrilla C.B., Solnick J.V. Modification of gastric mucin oligosaccharide expression in rhesus macaques after infection with Helicobacter pylori. Gastroenterology 2009, 137:1061-1071. 1071.
60. Linden S., Semino-Mora C., Liu H., Rick J., Dubois A. Role of mucin Lewis status in resistance to Helicobacter pylori infection in pediatric patients. Helicobacter 2010, 15:251-258.
61. Mahdavi J., Sonden B., Hurtig M., Olfat F.O., Forsberg L., Roche N., Angstrom J., Larsson T., Teneberg S., Karlsson K.A., Altraja S., Wadstrom T., Kersulyte D., Berg D.E., Dubois A., Petersson C., Magnusson K.E., Norberg T., Lindh F., Lundskog B.B., Arnqvist A., Hammarstrom L., Boren T. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002, 297:573-578.
62. Matsuzwa M., Ota H., Hayama M., Zhang M.X., Sano K., Honda T., Ueno I., Akamatsu T., Nakayama J. Helicobacter pylori infection up-regulates gland mucous cell-type mucins in gastric pyloric mucosa. Helicobacter 2003, 8:594-600.
63. Tardif K.D., Siddiqui A. Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells. J. Virol. 2003, 77:11644-11650.
64. Azuma Y., Murata M., Matsumoto K. Alteration of sugar chains on alpha(1)-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro. Clin. Chim. Acta 2000, 294:93-103.
65. Higai K., Miyazaki N., Azuma Y., Matsumoto K. Interleukin-1beta induces Sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene. FEBS Lett. 2006, 580:6069-6075.
66. Ishibashi Y., Inouye Y., Okano T., Taniguchi A. Regulation of Sialyl-Lewis x epitope expression by TNF-alpha and EGF in an airway carcinoma cell line. Glycoconj. J. 2005, 22:53-62.
67. Ishibashi Y., Imai S., Inouye Y., Okano T., Taniguchi A. Effects of carbocisteine on Sialyl-Lewis x expression in an airway carcinoma cell line stimulated with tumor necrosis factor-alpha. Eur. J. Pharmacol. 2006, 530:223-228.
68. Mackiewicz A., Rose-John S., Schooltink H., Laciak M., Gorny A., Heinrich P.C. Soluble human interleukin-6-receptor modulates interleukin-6-dependent N-glycosylation of alpha 1-protease inhibitor secreted by HepG2 cells. FEBS Lett. 1992, 306:257-261.
69. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
70. Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.
71. Ochoa-Reparaz J., Mielcarz D.W., Wang Y., Begum-Haque S., Dasgupta S., Kasper D.L., Kasper L.H. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal. Immunol. 2010, 3:487-495.
72. Kreisman L.S., Cobb B.A. Glycoantigens induce human peripheral Tr1 cell differentiation with gut-homing specialization. J. Biol. Chem. 2011, 286:8810-8818.